Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 103 entries
Sorted by: Best Match Show Resources per page
Calcitonin Gene-related Peptide Causes Intraspinal Spreading of Substance P Released by Peripheral Stimulation.

The European journal of neuroscience

Schaible HG, Hope PJ, Lang CW, Duggan AW.
PMID: 12106319
Eur J Neurosci. 1992;4(8):750-7. doi: 10.1111/j.1460-9568.1992.tb00184.x.

Experiments were performed in barbiturate-anaesthetized, spinalized cats to investigate the effect of calcitonin gene-related peptide (CGRP) on the spatial distribution of immunoreactive substance P (ir-SP) in the spinal cord released by electrical nerve stimulation and noxious mechanical stimuli. The...

Cite
Schaible HG, Hope PJ, Lang CW, et al. Calcitonin Gene-related Peptide Causes Intraspinal Spreading of Substance P Released by Peripheral Stimulation. Eur J Neurosci. 1992;4(8):750-7doi: 10.1111/j.1460-9568.1992.tb00184.x.
Schaible, H. G., Hope, P. J., Lang, C. W., & Duggan, A. W. (1992). Calcitonin Gene-related Peptide Causes Intraspinal Spreading of Substance P Released by Peripheral Stimulation. The European journal of neuroscience, 4(8), 750-7. https://doi.org/10.1111/j.1460-9568.1992.tb00184.x
Schaible, H G, et al. "Calcitonin Gene-related Peptide Causes Intraspinal Spreading of Substance P Released by Peripheral Stimulation." The European journal of neuroscience vol. 4,8 (1992): 750-7. doi: https://doi.org/10.1111/j.1460-9568.1992.tb00184.x
Schaible HG, Hope PJ, Lang CW, Duggan AW. Calcitonin Gene-related Peptide Causes Intraspinal Spreading of Substance P Released by Peripheral Stimulation. Eur J Neurosci. 1992;4(8):750-7. doi: 10.1111/j.1460-9568.1992.tb00184.x. PMID: 12106319.
Copy Download .nbib Format: NLM
Reporting of sex as a variable in cardiovascular studies using cultured cells.

Biology of sex differences

Taylor KE, Vallejo-Giraldo C, Schaible NS, Zakeri R, Miller VM.
PMID: 22060014
Biol Sex Differ. 2011 Nov 07;2:11. doi: 10.1186/2042-6410-2-11.

BACKGROUND: Chromosomal complement, including that provided by the sex chromosomes, influences expression of proteins and molecular signaling in every cell. However, less than 50% of the scientific studies published in 2009 using experimental animals reported sex as a biological...

Cite
Taylor KE, Vallejo-Giraldo C, Schaible NS, et al. Reporting of sex as a variable in cardiovascular studies using cultured cells. Biol Sex Differ. 2011;2:11doi: 10.1186/2042-6410-2-11.
Taylor, K. E., Vallejo-Giraldo, C., Schaible, N. S., Zakeri, R., & Miller, V. M. (2011). Reporting of sex as a variable in cardiovascular studies using cultured cells. Biology of sex differences, 211. https://doi.org/10.1186/2042-6410-2-11
Taylor, K Efua, et al. "Reporting of sex as a variable in cardiovascular studies using cultured cells." Biology of sex differences vol. 2 (2011): 11. doi: https://doi.org/10.1186/2042-6410-2-11
Taylor KE, Vallejo-Giraldo C, Schaible NS, Zakeri R, Miller VM. Reporting of sex as a variable in cardiovascular studies using cultured cells. Biol Sex Differ. 2011 Nov 07;2:11. doi: 10.1186/2042-6410-2-11. PMID: 22060014; PMCID: PMC3224776.
Copy Download .nbib Format: NLM
Novel microsatellite markers for the saltmarsh sharp-tailed sparrow, Ammodramus caudacutus (Aves: Passeriformes).

Molecular ecology resources

Hill CE, Tomko S, Hagen C, Schable NA, Glenn TC.
PMID: 21585730
Mol Ecol Resour. 2008 Jan;8(1):113-5. doi: 10.1111/j.1471-8286.2007.01885.x.

We have developed eight high-quality microsatellite DNA loci for the saltmarsh sharp-tailed sparrow and one additional locus with evidence of null alleles. In a sample of 250-350 individuals, the average number of alleles per locus was 14.7 and average...

Cite
Hill CE, Tomko S, Hagen C, et al. Novel microsatellite markers for the saltmarsh sharp-tailed sparrow, Ammodramus caudacutus (Aves: Passeriformes). Mol Ecol Resour. 2008;8(1):113-5doi: 10.1111/j.1471-8286.2007.01885.x.
Hill, C. E., Tomko, S., Hagen, C., Schable, N. A., & Glenn, T. C. (2008). Novel microsatellite markers for the saltmarsh sharp-tailed sparrow, Ammodramus caudacutus (Aves: Passeriformes). Molecular ecology resources, 8(1), 113-5. https://doi.org/10.1111/j.1471-8286.2007.01885.x
Hill, Christopher E, et al. "Novel microsatellite markers for the saltmarsh sharp-tailed sparrow, Ammodramus caudacutus (Aves: Passeriformes)." Molecular ecology resources vol. 8,1 (2008): 113-5. doi: https://doi.org/10.1111/j.1471-8286.2007.01885.x
Hill CE, Tomko S, Hagen C, Schable NA, Glenn TC. Novel microsatellite markers for the saltmarsh sharp-tailed sparrow, Ammodramus caudacutus (Aves: Passeriformes). Mol Ecol Resour. 2008 Jan;8(1):113-5. doi: 10.1111/j.1471-8286.2007.01885.x. PMID: 21585730.
Copy Download .nbib Format: NLM
[Der Schmerz - the leading German-language pain journal].

Schmerz (Berlin, Germany)

Radbruch L, Schaible HG.
PMID: 25465245
Schmerz. 2014 Dec;28(6):569-70. doi: 10.1007/s00482-014-1498-z.

No abstract available.

Cite
Radbruch L, Schaible HG. Der Schmerz - die führende deutschsprachige Schmerzzeitschrift. [Der Schmerz - the leading German-language pain journal]. Schmerz. 2014;28(6):569-70doi: 10.1007/s00482-014-1498-z.
Radbruch, L., & Schaible, H. G. (2014). Der Schmerz - die führende deutschsprachige Schmerzzeitschrift. [Der Schmerz - the leading German-language pain journal]. Schmerz (Berlin, Germany), 28(6), 569-70. https://doi.org/10.1007/s00482-014-1498-z
Radbruch, L, and Schaible, H-G. "Der Schmerz - die führende deutschsprachige Schmerzzeitschrift." [Der Schmerz - the leading German-language pain journal]. Schmerz (Berlin, Germany) vol. 28,6 (2014): 569-70. doi: https://doi.org/10.1007/s00482-014-1498-z
Radbruch L, Schaible HG. Der Schmerz - die führende deutschsprachige Schmerzzeitschrift. [Der Schmerz - the leading German-language pain journal]. Schmerz. 2014 Dec;28(6):569-70. doi: 10.1007/s00482-014-1498-z. German. PMID: 25465245.
Copy Download .nbib Format: NLM
Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis.

Journal of internal medicine

Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T.
PMID: 29806961
J Intern Med. 2018 May 28; doi: 10.1111/joim.12780. Epub 2018 May 28.

According to the World Health Organization (WHO), tuberculosis is the leading cause of death attributed to a single microbial pathogen worldwide. In addition to the large number of patients affected by tuberculosis, the emergence of Mycobacterium tuberculosis drug-resistance is...

Cite
Lange C, Alghamdi WA, Al-Shaer MH, et al. Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. J Intern Med. 2018;doi: 10.1111/joim.12780.
Lange, C., Alghamdi, W. A., Al-Shaer, M. H., Brighenti, S., Diacon, A. H., DiNardo, A. R., Grobbel, H. P., Gröschel, M. I., von Groote-Bidlingmaier, F., Hauptmann, M., Heyckendorf, J., Köhler, N., Kohl, T. A., Merker, M., Niemann, S., Peloquin, C. A., Reimann, M., Schaible, U. E., Schaub, D., Schleusener, V., Thye, T., & Schön, T. (2018). Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. Journal of internal medicine, . https://doi.org/10.1111/joim.12780
Lange, C, et al. "Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis." Journal of internal medicine vol. (2018). doi: https://doi.org/10.1111/joim.12780
Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T. Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. J Intern Med. 2018 May 28; doi: 10.1111/joim.12780. Epub 2018 May 28. PMID: 29806961.
Copy Download .nbib Format: NLM
[A new rubric in Der Schmerz: "PAIN CLINICAL UPDATES"].

Schmerz (Berlin, Germany)

Schaible HG, Radbruch L.
PMID: 29404684
Schmerz. 2018 Apr;32(2):89. doi: 10.1007/s00482-018-0274-x.

No abstract available.

Cite
Schaible HG, Radbruch L. Neue Rubrik „PAIN CLINICAL UPDATES“ in Der Schmerz. [A new rubric in Der Schmerz: "PAIN CLINICAL UPDATES"]. Schmerz. 2018;32(2):89doi: 10.1007/s00482-018-0274-x.
Schaible, H. G., & Radbruch, L. (2018). Neue Rubrik „PAIN CLINICAL UPDATES“ in Der Schmerz. [A new rubric in Der Schmerz: "PAIN CLINICAL UPDATES"]. Schmerz (Berlin, Germany), 32(2), 89. https://doi.org/10.1007/s00482-018-0274-x
Schaible, H-G, and Radbruch, L. "Neue Rubrik „PAIN CLINICAL UPDATES“ in Der Schmerz." [A new rubric in Der Schmerz: "PAIN CLINICAL UPDATES"]. Schmerz (Berlin, Germany) vol. 32,2 (2018): 89. doi: https://doi.org/10.1007/s00482-018-0274-x
Schaible HG, Radbruch L. Neue Rubrik „PAIN CLINICAL UPDATES“ in Der Schmerz. [A new rubric in Der Schmerz: "PAIN CLINICAL UPDATES"]. Schmerz. 2018 Apr;32(2):89. doi: 10.1007/s00482-018-0274-x. German. PMID: 29404684.
Copy Download .nbib Format: NLM
Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity.

Frontiers in immunology

Patin EC, Orr SJ, Schaible UE.
PMID: 28791019
Front Immunol. 2017 Jul 25;8:861. doi: 10.3389/fimmu.2017.00861. eCollection 2017.

The macrophage-inducible C-type lectin (Mincle) is an innate immune receptor on myeloid cells sensing diverse entities including pathogens and damaged cells. Mincle was first described as a receptor for the mycobacterial cell wall glycolipid, trehalose-6,6'-dimycolate, or cord factor, and...

Cite
Patin EC, Orr SJ, Schaible UE. Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity. Front Immunol. 2017;8:861doi: 10.3389/fimmu.2017.00861.
Patin, E. C., Orr, S. J., & Schaible, U. E. (2017). Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity. Frontiers in immunology, 8861. https://doi.org/10.3389/fimmu.2017.00861
Patin, Emmanuel C, et al. "Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity." Frontiers in immunology vol. 8 (2017): 861. doi: https://doi.org/10.3389/fimmu.2017.00861
Patin EC, Orr SJ, Schaible UE. Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity. Front Immunol. 2017 Jul 25;8:861. doi: 10.3389/fimmu.2017.00861. eCollection 2017. PMID: 28791019; PMCID: PMC5525440.
Copy Download .nbib Format: NLM
Corrigendum to "Characterization of Bone Marrow Mononuclear Cells on Biomaterials for Bone Tissue Engineering In Vitro".

BioMed research international

Henrich D, Verboket R, Schaible A, Kontradowitz K, Oppermann E, Brune JC, Nau C, Meier S, Bonig H, Marzi I, Seebach C.
PMID: 26417593
Biomed Res Int. 2015;2015:325203. doi: 10.1155/2015/325203. Epub 2015 Aug 31.

No abstract available.

Cite
Henrich D, Verboket R, Schaible A, et al. Corrigendum to "Characterization of Bone Marrow Mononuclear Cells on Biomaterials for Bone Tissue Engineering In Vitro". Biomed Res Int. 2015;2015:325203doi: 10.1155/2015/325203.
Henrich, D., Verboket, R., Schaible, A., Kontradowitz, K., Oppermann, E., Brune, J. C., Nau, C., Meier, S., Bonig, H., Marzi, I., & Seebach, C. (2015). Corrigendum to "Characterization of Bone Marrow Mononuclear Cells on Biomaterials for Bone Tissue Engineering In Vitro". BioMed research international, 2015325203. https://doi.org/10.1155/2015/325203
Henrich, Dirk, et al. "Corrigendum to "Characterization of Bone Marrow Mononuclear Cells on Biomaterials for Bone Tissue Engineering In Vitro"." BioMed research international vol. 2015 (2015): 325203. doi: https://doi.org/10.1155/2015/325203
Henrich D, Verboket R, Schaible A, Kontradowitz K, Oppermann E, Brune JC, Nau C, Meier S, Bonig H, Marzi I, Seebach C. Corrigendum to "Characterization of Bone Marrow Mononuclear Cells on Biomaterials for Bone Tissue Engineering In Vitro". Biomed Res Int. 2015;2015:325203. doi: 10.1155/2015/325203. Epub 2015 Aug 31. PMID: 26417593; PMCID: PMC4568334.
Copy Download .nbib Format: NLM
[Tracing the neurobiological causes of chronic pain].

Schmerz (Berlin, Germany)

Schaible HG, Radbruch L.
PMID: 27028534
Schmerz. 2016 Apr;30(2):125-6. doi: 10.1007/s00482-016-0108-7.

No abstract available.

Cite
Schaible HG, Radbruch L. Den neurobiologischen Grundlagen des chronischen Schmerzes auf der Spur. [Tracing the neurobiological causes of chronic pain]. Schmerz. 2016;30(2):125-6doi: 10.1007/s00482-016-0108-7.
Schaible, H. G., & Radbruch, L. (2016). Den neurobiologischen Grundlagen des chronischen Schmerzes auf der Spur. [Tracing the neurobiological causes of chronic pain]. Schmerz (Berlin, Germany), 30(2), 125-6. https://doi.org/10.1007/s00482-016-0108-7
Schaible, H-G, and Radbruch, L. "Den neurobiologischen Grundlagen des chronischen Schmerzes auf der Spur." [Tracing the neurobiological causes of chronic pain]. Schmerz (Berlin, Germany) vol. 30,2 (2016): 125-6. doi: https://doi.org/10.1007/s00482-016-0108-7
Schaible HG, Radbruch L. Den neurobiologischen Grundlagen des chronischen Schmerzes auf der Spur. [Tracing the neurobiological causes of chronic pain]. Schmerz. 2016 Apr;30(2):125-6. doi: 10.1007/s00482-016-0108-7. German. PMID: 27028534.
Copy Download .nbib Format: NLM
Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial.

Pilot and feasibility studies

Blank S, Knebel P, Haag GM, Bruckner T, Klaiber U, Burian M, Schaible A, Sisic L, Schmidt T, Diener MK, Ott K.
PMID: 27965838
Pilot Feasibility Stud. 2016 Apr 04;2:18. doi: 10.1186/s40814-016-0059-x. eCollection 2016.

BACKGROUND: Neoadjuvant chemotherapy is a standard of care for patients with adenocarcinoma of the esophagus and stomach in Europe, but still only 20-40 % respond to therapy and the critical issue; how to treat nonresponding patients is still unclear....

Cite
Blank S, Knebel P, Haag GM, et al. Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial. Pilot Feasibility Stud. 2016;2:18doi: 10.1186/s40814-016-0059-x.
Blank, S., Knebel, P., Haag, G. M., Bruckner, T., Klaiber, U., Burian, M., Schaible, A., Sisic, L., Schmidt, T., Diener, M. K., & Ott, K. (2016). Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial. Pilot and feasibility studies, 218. https://doi.org/10.1186/s40814-016-0059-x
Blank, Susanne, et al. "Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial." Pilot and feasibility studies vol. 2 (2016): 18. doi: https://doi.org/10.1186/s40814-016-0059-x
Blank S, Knebel P, Haag GM, Bruckner T, Klaiber U, Burian M, Schaible A, Sisic L, Schmidt T, Diener MK, Ott K. Immediate tumor resection in patients with locally advanced gastroesophageal adenocarcinoma with nonresponse to chemotherapy after 4 weeks of treatment versus resection after completion of chemotherapy (OPTITREAT trial, DRKS00004668): study protocol for a randomized controlled pilot trial. Pilot Feasibility Stud. 2016 Apr 04;2:18. doi: 10.1186/s40814-016-0059-x. eCollection 2016. PMID: 27965838; PMCID: PMC5153833.
Copy Download .nbib Format: NLM
Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.

The Journal of antimicrobial chemotherapy

Sherrard LJ, Schaible B, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Wolfgang MC, Muhlebach MS, Gilpin DF, Schneiders T, Stuart Elborn J, Tunney MM.
PMID: 30351435
J Antimicrob Chemother. 2018 Nov 01;73(11):3218. doi: 10.1093/jac/dky313.

No abstract available.

Cite
Sherrard LJ, Schaible B, Graham KA, et al. Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients. J Antimicrob Chemother. 2018;73(11):3218doi: 10.1093/jac/dky313.
Sherrard, L. J., Schaible, B., Graham, K. A., McGrath, S. J., McIlreavey, L., Hatch, J., Wolfgang, M. C., Muhlebach, M. S., Gilpin, D. F., Schneiders, T., Stuart Elborn, J., & Tunney, M. M. (2018). Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients. The Journal of antimicrobial chemotherapy, 73(11), 3218. https://doi.org/10.1093/jac/dky313
Sherrard, Laura J, et al. "Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients." The Journal of antimicrobial chemotherapy vol. 73,11 (2018): 3218. doi: https://doi.org/10.1093/jac/dky313
Sherrard LJ, Schaible B, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Wolfgang MC, Muhlebach MS, Gilpin DF, Schneiders T, Stuart Elborn J, Tunney MM. Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients. J Antimicrob Chemother. 2018 Nov 01;73(11):3218. doi: 10.1093/jac/dky313. PMID: 30351435; PMCID: PMC6927872.
Copy Download .nbib Format: NLM
Safety and efficacy of lacosamide versus phenytoin for refractory seizures in neurosurgical patients.

BMJ neurology open

Schaidle S, Greathouse K, McConnell D.
PMID: 34250484
BMJ Neurol Open. 2021 Jun 24;3(1):e000144. doi: 10.1136/bmjno-2021-000144. eCollection 2021.

BACKGROUND: Postoperative neurosurgical patients have increased risk of seizures. Traditional anti-epileptics, such as phenytoin, are not always effective and cause adverse effects. Levetiracetam is the first-line therapy due to its similar efficacy and more favourable side effect profile. However,...

Cite
Schaidle S, Greathouse K, McConnell D. Safety and efficacy of lacosamide versus phenytoin for refractory seizures in neurosurgical patients. BMJ Neurol Open. 2021;3(1):e000144doi: 10.1136/bmjno-2021-000144.
Schaidle, S., Greathouse, K., & McConnell, D. (2021). Safety and efficacy of lacosamide versus phenytoin for refractory seizures in neurosurgical patients. BMJ neurology open, 3(1), e000144. https://doi.org/10.1136/bmjno-2021-000144
Schaidle, Sarah, et al. "Safety and efficacy of lacosamide versus phenytoin for refractory seizures in neurosurgical patients." BMJ neurology open vol. 3,1 (2021): e000144. doi: https://doi.org/10.1136/bmjno-2021-000144
Schaidle S, Greathouse K, McConnell D. Safety and efficacy of lacosamide versus phenytoin for refractory seizures in neurosurgical patients. BMJ Neurol Open. 2021 Jun 24;3(1):e000144. doi: 10.1136/bmjno-2021-000144. eCollection 2021. PMID: 34250484; PMCID: PMC8231016.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 103 entries